Further processing options

Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the AT...

Saved in:

Bibliographic Details
Authors and Corporations: Lux, Michael P., Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt, Schneeweiss, Andreas
Title: Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
Type of Resource: E-Article
Language: English
published:
Basel Karger 2010
Online-Ausg.. 2014
Series: , Onkologie 2010;33:155–166, ISSN: 0378-584X
Subjects:
Source: Qucosa
LEADER 01859nab a2200541 c 4500
001 22-14-qucosa-134902
007 cr
008 2010 eng
037 |a urn:nbn:de:bsz:14-qucosa-134902 
041 |a eng 
082 |a 610 
084 |a Xa 10000  |2 rvk 
100 |a Lux, Michael P. 
245 |a Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System 
264 |a Basel  |b Karger  |c 2010 
533 |a Online-Ausg.  |d 2014  |e Online-Ressource (Text)  |f Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden 
650 |a Anastrozol 
650 |a Kosten-Effektivitäts-Analyse 
650 |a Kosten-Nutzwert-Analyse 
650 |a Icer 
650 |a Incremental Cost-Effectiveness Ratio 
650 |a Tamoxifen 
650 |a Qaly 
650 |a Anastrozole 
650 |a Cost-Effectiveness Analysis 
650 |a Cost-Utility Analysis 
650 |a Incremental Cost-Effectiveness Ratio 
650 |a Tamoxifen 
650 |a Qaly 
700 |a Wöckel, Achim 
700 |a Benedict, Agnes 
700 |a Buchholz, Stefan 
700 |a Kreif, Noémi 
700 |a Harbeck, Nadia 
700 |a Kreienberg, Rolf 
700 |a Kaufmann, Manfred 
700 |a Beckmann, Matthias W. 
700 |a Jonat, Walter 
700 |a Hadji, Peyman 
700 |a Distler, Wolfgang 
700 |a Raab, Guenther 
700 |a Tesch, Hans 
700 |a Weyers, Georg 
700 |a Possinger, Kurt 
700 |a Schneeweiss, Andreas 
773 |g Onkologie 2010;33:155–166, ISSN: 0378-584X 
856 4 0 |q text/html  |u https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa-134902  |z Online-Zugriff 
980 |a 14-qucosa-134902  |b 22  |c sid-22-col-qucosa 
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Cost-Effectiveness+Analysis+of+Anastrozole+versus+Tamoxifen+in+Adjuvant+Therapy+for+Early-Stage+Breast+Cancer+%E2%80%93+a+Health-Economic+Analysis+Based+on+the+100-Month+Analysis+of+the+ATAC+Trial+and+the+German+Health+System&rft.date=2010&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=Lux%2C+Michael+P.&rft.pub=Karger&rft.format=ElectronicSerialComponentPart&rft.language=English
SOLR
_version_ 1792336806019072000
access_facet Electronic Resources
author Lux, Michael P.
author2 Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt, Schneeweiss, Andreas
author2_role , , , , , , , , , , , , , , ,
author2_variant a w aw, a b ab, s b sb, n k nk, n h nh, r k rk, m k mk, m w b mw mwb, w j wj, p h ph, w d wd, g r gr, h t ht, g w gw, k p kp, a s as
author_facet Lux, Michael P., Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt, Schneeweiss, Andreas
author_role
author_sort Lux, Michael P.
author_variant m p l mp mpl
building Library A
callnumber-sort
collection sid-22-col-qucosa
dewey-full 610
dewey-hundreds 600 - Technology
dewey-ones 610 - Medicine & health
dewey-raw 610
dewey-search 610
dewey-sort 3610
dewey-tens 610 - Medicine & health
facet_avail Online, Free
finc_class_facet Technik, Medizin
fincclass_txtF_mv medicine
format ElectronicSerialComponentPart
format_access_txtF_mv Article, E-Article
format_de105 Ebook
format_de14 Article, E-Article
format_de15 Article, E-Article
format_del152 Buch
format_detail_txtF_mv text-online-journal-child
format_dezi4 Journal
format_finc Article, E-Article
format_legacy ElectronicArticle
format_legacy_nrw Article, E-Article
format_nrw Article, E-Article
format_strict_txtF_mv E-Article
geogr_code not assigned
geogr_code_person not assigned
hierarchy_sequence Onkologie 2010;33:155–166, ISSN: 0378-584X
id 22-14-qucosa-134902
illustrated Not Illustrated
imprint Basel, Karger, 2010
imprint_str_mv Online-Ausg.: 2014
institution DE-105, DE-Gla1, DE-Brt1, DE-D161, DE-540, DE-Pl11, DE-Rs1, DE-Bn3, DE-Zi4, DE-Zwi2, DE-D117, DE-Mh31, DE-D275, DE-Ch1, DE-15, DE-D13, DE-L242, DE-L229, DE-L328
is_hierarchy_id
is_hierarchy_title
language English
last_indexed 2024-03-01T15:06:17.344Z
match_str lux2010costeffectivenessanalysisofanastrozoleversustamoxifeninadjuvanttherapyforearlystagebreastcancerahealtheconomicanalysisbasedonthe100monthanalysisoftheatactrialandthegermanhealthsystem
mega_collection Qucosa
publishDate 2010
publishDateSort 2010
publishPlace Basel
publisher Karger
record_format marcfinc
record_id 14-qucosa-134902
recordtype marcfinc
rvk_facet Xa 10000
score 16,905733
source_id 22
spelling Lux, Michael P., Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System, Basel Karger 2010, Online-Ausg. 2014 Online-Ressource (Text) Saechsische Landesbibliothek- Staats- und Universitaetsbibliothek Dresden, Anastrozol, Kosten-Effektivitäts-Analyse, Kosten-Nutzwert-Analyse, Icer, Incremental Cost-Effectiveness Ratio, Tamoxifen, Qaly, Anastrozole, Cost-Effectiveness Analysis, Cost-Utility Analysis, Wöckel, Achim, Benedict, Agnes, Buchholz, Stefan, Kreif, Noémi, Harbeck, Nadia, Kreienberg, Rolf, Kaufmann, Manfred, Beckmann, Matthias W., Jonat, Walter, Hadji, Peyman, Distler, Wolfgang, Raab, Guenther, Tesch, Hans, Weyers, Georg, Possinger, Kurt, Schneeweiss, Andreas, Onkologie 2010;33:155–166, ISSN: 0378-584X, text/html https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa-134902 Online-Zugriff
spellingShingle Lux, Michael P., Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System, Anastrozol, Kosten-Effektivitäts-Analyse, Kosten-Nutzwert-Analyse, Icer, Incremental Cost-Effectiveness Ratio, Tamoxifen, Qaly, Anastrozole, Cost-Effectiveness Analysis, Cost-Utility Analysis
title Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_auth Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_full Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_fullStr Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_full_unstemmed Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_in_hierarchy
title_short Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
title_sort cost effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early stage breast cancer a health economic analysis based on the 100 month analysis of the atac trial and the german health system
title_unstemmed Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – a Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System
topic Anastrozol, Kosten-Effektivitäts-Analyse, Kosten-Nutzwert-Analyse, Icer, Incremental Cost-Effectiveness Ratio, Tamoxifen, Qaly, Anastrozole, Cost-Effectiveness Analysis, Cost-Utility Analysis
topic_facet Anastrozol, Kosten-Effektivitäts-Analyse, Kosten-Nutzwert-Analyse, Icer, Incremental Cost-Effectiveness Ratio, Tamoxifen, Qaly, Anastrozole, Cost-Effectiveness Analysis, Cost-Utility Analysis
url https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa-134902
urn urn:nbn:de:bsz:14-qucosa-134902